Ra Capital Management, L.P. Regulus Therapeutics Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 766,834 shares of RGLS stock, worth $950,874. This represents 0.02% of its overall portfolio holdings.
Number of Shares
766,834
Previous 6,250,000
87.73%
Holding current value
$950,874
Previous $11.2 Million
89.25%
% of portfolio
0.02%
Previous 0.17%
Shares
3 transactions
Others Institutions Holding RGLS
# of Institutions
75Shares Held
56.5MCall Options Held
79.3KPut Options Held
20.3K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$15.9 Million0.05% of portfolio
-
Nea Management Company, LLC Timonium, MD6.47MShares$8.02 Million0.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$6.2 Million1.15% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$5.29 Million1.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$5.07 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $18.1M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...